Developer docs
API playgroundTry for free, no card

Search company profiles

RMBIO

Full company profile

uuid000cxun

Namestring
RMBIO
Legal namestring
Rocky Mountain Biologicals, LLC
Websiteurl
rmbio.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

RMBIO (Rocky Mountain Biologicals, LLC) is a privately held specialty bioproducts manufacturer founded in 2004 and based in Missoula, Montana. The company produces sera, protein fractions, and cell culture media supplements for the research, bioprocessing, and clinical diagnostic industries. Its flagship offerings include the proprietary Fetalgro and Fetalgro EX lines — formulated FBS replacements positioned as cost-effective alternatives to traditional fetal bovine serum — alongside US Origin and USDA-approved FBS variants, treated sera (heat-inactivated, gamma-irradiated, IgG-depleted, dialyzed), specialty sera (calf, equine, porcine), classical cell culture media (DMEM, RPMI 1640, MEM, Leibovitz L-15), growth factors (bFGF, IGF-1), and diagnostic adjacencies such as thrombin, cholesterol concentrates, and Viral Transport Medium used in SARS-CoV-2 sample collection. Manufacturing is conducted at an FDA-registered, GMP-compliant, ISIA-certified facility in Missoula, with chain-of-custody validated to 9CFR standards.

The company operates a direct-to-consumer e-commerce model with global shipping, serving research laboratories, bioprocessing developers, clinical diagnostic manufacturers, and animal health customers. Pricing is per-unit and varies materially by grade: entry-level treated and specialty sera from $16-$42, Fetalgro standard from $28, Fetalgro EX at $25-$184, and premium US Origin FBS at $75-$670 per 500 ml. Revenue is not disclosed; with an employee count of 11-50 and the absence of any public funding rounds or M&A activity, RMBIO functions as a privately held, founder-led specialty supplier whose competitive position rests on regulatory credentials, proprietary serum alternatives, and breadth across adjacent biological inputs rather than scale or capital intensity.

Short descriptiontext

RMBIO is a Missoula, Montana-based specialty bioproducts manufacturer producing sera, protein fractions, and cell culture media supplements — including proprietary Fetalgro FBS replacements — for research, bioprocessing, and clinical diagnostic customers via a direct e-commerce channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMissoula, United States
HQ citystring
Missoula
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fetal bovine serum, cell culture media, protein fractions, bioprocessing reagents, diagnostic sera
Industry1 code
PRIMARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Cell Culture Media and Biological Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Sera and Protein Products
TypeOne Time License
Description

Direct product sales of cell culture media supplements, sera, protein fractions, and related biological products to research, bioprocessing, and clinical diagnostic industries. Revenue generated through e-commerce storefront and direct sales.

rmbio.com
2Custom Solutions and Bulk Orders
TypeOne Time License
Description

Special order capabilities for custom packaging, custom specifications, and bulk quantities. Free samples available for select products to drive adoption.

rmbio.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Operations, Personnel, Technology or R&D
Pricing details6 tiers
1Fetalgro EX Premium FBS Replacement
ModelUnit PricingBilling cadencePay-as-you-go
Notes

50 ML: $25.00, 500 ML: $184.00. Free 50ml sample available upon request (limited time).

rmbio.com
2Fetalgro Standard FBS Replacement
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting from $28.00

rmbio.com
3Premium Fetal Bovine Serum, US Origin
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting from $75.00 (500ml: $670.00)

rmbio.com
4Basic Fibroblast Growth Factor bFGF
ModelUnit PricingBilling cadencePay-as-you-go
Notes

10µg: $120.00, 50µg: $220.00

rmbio.com
5FBS USDA Approved Origin
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$42.00 per unit (currently out of stock)

rmbio.com
6Phosphate-Buffered Saline (PBS)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting from $16.25

rmbio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Fetalgro EX®
Description

Premium bovine growth serum serving as a FBS replacement, designed to meet or exceed cell growth promotion characteristics of fetal bovine serum in a wide range of cell lines.

rmbio.com
+2 more records
Core offering1 text field

RMBIO manufactures and supplies sera, protein fractions, and cell culture media supplements used in research, bioprocessing, and clinical diagnostic applications. The company produces biological reagents that support cell culture workflows for pharmaceutical, biotechnology, and diagnostic laboratory customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Fetalgro EX demonstrated 150% more cell growth than FBS in NIH-3T3 cell line
+4 more records
Product overview1 text field

RMBIO (Rocky Mountain Biologicals) is a manufacturer of high-quality biological products for the life sciences and bioprocessing industries. The company's product portfolio centers around Fetal Bovine Serum (FBS) products and their proprietary FBS alternatives, particularly Fetalgro EX® and Fetalgro® Bovine Growth Serum. These core offerings are complemented by a comprehensive range of cell culture media supplements including treated sera (heat inactivated, gamma irradiated, IgG depleted, dialyzed), calf sera (iron fortified, formula fed, newborn), and specialty biologicals such as equine serum, porcine serum, growth factors (bFGF), enzymes (porcine trypsin), and cholesterol concentrates. RMBIO also provides essential cell culture media formulations (DMEM, RPMI 1640, MEM, Leibovitz L-15), buffer solutions (PBS), and diagnostic products including viral transport medium and thrombin. The company operates cGMP-compliant, FDA-registered manufacturing facilities and holds ISIA traceability certification, serving research, biopharmaceutical, diagnostic, and animal health markets.

Product and service3 records
1Research and Bioprocessing Sera
CategoryCell Culture Media and Sera
Description

Manufactured sera products supplied to research, bioprocessing, and clinical diagnostic customers for cell culture and related applications.

2Protein Fractions
CategoryProtein-based Reagents
Description

Protein fraction products manufactured for use in research, bioprocessing, and clinical diagnostic workflows.

3Cell Culture Media Supplements
CategoryCell Culture Media
Description

Supplements used to support cell culture media formulations for research, bioprocessing, and clinical diagnostic applications.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Gibco is the dominant global brand for FBS, cell culture media, and sera, serving the same bioprocessing, research, and diagnostic customers as RMBIO. While offerings are far broader, the core product overlap directly competes with RMBIO's sera and supplements.

TypeBroad incumbent
Description

Sigma-Aldrich/Merck offers an extensive cell culture media, FBS, and serum product catalog and is a primary competitor in research and bioprocessing inputs. Direct overlap with RMBIO's cell culture media and sera lines.

TypeBroad incumbent
Description

Cytiva supplies cell culture media, sera, and bioprocessing solutions to vaccine and therapeutic manufacturers. Overlaps with RMBIO's bioprocessing customer base and media offering.

4Atlas Biologicals
TypeDirect peer
Description

Atlas Biologicals is a US-based specialty serum and cell culture media supplier focused on FBS and animal sera, closely comparable to RMBIO in product mix and customer base.

TypeDirect peer
Description

Peak Serum is a US-based specialty FBS and serum products supplier, closely matching RMBIO's niche in premium and treated sera for research and bioprocessing.

TypeDirect peer
Description

Gemini Bio manufactures cell culture media, sera, and reagents for research and bioprocessing. Its catalog and customer base substantially overlap with RMBIO's.

7Corning Life Sciences
TypeBroad incumbent
Description

Corning supplies cell culture media, sera, and plasticware with a broad catalog. Overlaps with RMBIO in media and supplementary reagents for cell culture.

TypeBroad incumbent
Description

Lonza is a major global bioprocessing and cell culture media supplier, providing sera, media, and custom manufacturing to pharma and cell therapy customers. Directly competes for bioprocessing and vaccine media spend.

TypeDirect peer
Description

Bovogen is an Australian-based specialty FBS and animal serum producer with a strong catalog of treated sera, equivalent to RMBIO's treated sera and Fetalgro offerings.

TypeDirect peer
Description

Animal Technologies is a specialty animal-derived sera and biological products supplier, with direct overlap to RMBIO's core sera and protein fraction portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RMBIO

Cell Culture Media and Biological Reagentsrmbio.com

RMBIO is a Missoula, Montana-based specialty bioproducts manufacturer producing sera, protein fractions, and cell culture media supplements — including proprietary Fetalgro FBS replacements — for research, bioprocessing, and clinical diagnostic customers via a direct e-commerce channel.

What RMBIO does

RMBIO (Rocky Mountain Biologicals, LLC) is a privately held specialty bioproducts manufacturer founded in 2004 and based in Missoula, Montana. The company produces sera, protein fractions, and cell culture media supplements for the research, bioprocessing, and clinical diagnostic industries. Its flagship offerings include the proprietary Fetalgro and Fetalgro EX lines — formulated FBS replacements positioned as cost-effective alternatives to traditional fetal bovine serum — alongside US Origin and USDA-approved FBS variants, treated sera (heat-inactivated, gamma-irradiated, IgG-depleted, dialyzed), specialty sera (calf, equine, porcine), classical cell culture media (DMEM, RPMI 1640, MEM, Leibovitz L-15), growth factors (bFGF, IGF-1), and diagnostic adjacencies such as thrombin, cholesterol concentrates, and Viral Transport Medium used in SARS-CoV-2 sample collection. Manufacturing is conducted at an FDA-registered, GMP-compliant, ISIA-certified facility in Missoula, with chain-of-custody validated to 9CFR standards.

The company operates a direct-to-consumer e-commerce model with global shipping, serving research laboratories, bioprocessing developers, clinical diagnostic manufacturers, and animal health customers. Pricing is per-unit and varies materially by grade: entry-level treated and specialty sera from $16-$42, Fetalgro standard from $28, Fetalgro EX at $25-$184, and premium US Origin FBS at $75-$670 per 500 ml. Revenue is not disclosed; with an employee count of 11-50 and the absence of any public funding rounds or M&A activity, RMBIO functions as a privately held, founder-led specialty supplier whose competitive position rests on regulatory credentials, proprietary serum alternatives, and breadth across adjacent biological inputs rather than scale or capital intensity.

RMBIO firmographics

Firmographics
Name
RMBIO
Legal name
Rocky Mountain Biologicals, LLC
Website
https://rmbio.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
RMBIO is a Missoula, Montana-based specialty bioproducts manufacturer producing sera, protein fractions, and cell culture media supplements — including proprietary Fetalgro FBS replacements — for research, bioprocessing, and clinical diagnostic customers via a direct e-commerce channel.
Ownership category
akta.pro rank

RMBIO industry classification

Industry
Product category
Cell Culture Media and Biological Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAAJAI
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Fetal bovine serum
  • Cell culture media
  • Protein fractions
  • Bioprocessing reagents
  • Diagnostic sera

Where RMBIO is headquartered

Location

Headquarters

HQ city
Missoula
HQ country
United States
HQ region
North America

Offices2 records

Markets served

RMBIO business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

  1. Sera and Protein Products: Direct product sales of cell culture media supplements, sera, protein fractions, and related biological products to research, bioprocessing, and clinical diagnostic industries. Revenue generated through e-commerce storefront and direct sales.
  2. Custom Solutions and Bulk Orders: Special order capabilities for custom packaging, custom specifications, and bulk quantities. Free samples available for select products to drive adoption.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goFetalgro EX Premium FBS Replacement
Unit PricingPay-as-you-goFetalgro Standard FBS Replacement
Unit PricingPay-as-you-goPremium Fetal Bovine Serum, US Origin
Unit PricingPay-as-you-goBasic Fibroblast Growth Factor bFGF
Unit PricingPay-as-you-goFBS USDA Approved Origin
Unit PricingPay-as-you-goPhosphate-Buffered Saline (PBS)

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

RMBIO product offering

Product offering

Core offering

RMBIO manufactures and supplies sera, protein fractions, and cell culture media supplements used in research, bioprocessing, and clinical diagnostic applications. The company produces biological reagents that support cell culture workflows for pharmaceutical, biotechnology, and diagnostic laboratory customers.

Product overview

RMBIO (Rocky Mountain Biologicals) is a manufacturer of high-quality biological products for the life sciences and bioprocessing industries. The company's product portfolio centers around Fetal Bovine Serum (FBS) products and their proprietary FBS alternatives, particularly Fetalgro EX® and Fetalgro® Bovine Growth Serum. These core offerings are complemented by a comprehensive range of cell culture media supplements including treated sera (heat inactivated, gamma irradiated, IgG depleted, dialyzed), calf sera (iron fortified, formula fed, newborn), and specialty biologicals such as equine serum, porcine serum, growth factors (bFGF), enzymes (porcine trypsin), and cholesterol concentrates. RMBIO also provides essential cell culture media formulations (DMEM, RPMI 1640, MEM, Leibovitz L-15), buffer solutions (PBS), and diagnostic products including viral transport medium and thrombin. The company operates cGMP-compliant, FDA-registered manufacturing facilities and holds ISIA traceability certification, serving research, biopharmaceutical, diagnostic, and animal health markets.

Differentiator

Problem solved

Functional benefit

Brands

  • Fetalgro EX®: Premium bovine growth serum serving as a FBS replacement, designed to meet or exceed cell growth promotion characteristics of fetal bovine serum in a wide range of cell lines.
  • Fetalgro®
  • Lipogro® Bovine Cholesterol Concentrate

Products and services

  • Research and Bioprocessing Sera Manufactured sera products supplied to research, bioprocessing, and clinical diagnostic customers for cell culture and related applications.
  • Protein Fractions Protein fraction products manufactured for use in research, bioprocessing, and clinical diagnostic workflows.
  • Cell Culture Media Supplements Supplements used to support cell culture media formulations for research, bioprocessing, and clinical diagnostic applications.

Quantifiable outcome

  • Fetalgro EX demonstrated 150% more cell growth than FBS in NIH-3T3 cell line
  • +4 more outcomes

Companies that use RMBIO

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

RMBIO technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

RMBIO partnerships and signals

Strategic signal

Scale indicators6 records

Expansion highlights4 records

RMBIO competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific (Gibco): Gibco is the dominant global brand for FBS, cell culture media, and sera, serving the same bioprocessing, research, and diagnostic customers as RMBIO. While offerings are far broader, the core product overlap directly competes with RMBIO's sera and supplements.
  • Merck (Sigma-Aldrich): Sigma-Aldrich/Merck offers an extensive cell culture media, FBS, and serum product catalog and is a primary competitor in research and bioprocessing inputs. Direct overlap with RMBIO's cell culture media and sera lines.
  • Cytiva: Cytiva supplies cell culture media, sera, and bioprocessing solutions to vaccine and therapeutic manufacturers. Overlaps with RMBIO's bioprocessing customer base and media offering.
  • Corning Life Sciences: Corning supplies cell culture media, sera, and plasticware with a broad catalog. Overlaps with RMBIO in media and supplementary reagents for cell culture.
  • Lonza: Lonza is a major global bioprocessing and cell culture media supplier, providing sera, media, and custom manufacturing to pharma and cell therapy customers. Directly competes for bioprocessing and vaccine media spend.

Direct peers

  • Atlas Biologicals: Atlas Biologicals is a US-based specialty serum and cell culture media supplier focused on FBS and animal sera, closely comparable to RMBIO in product mix and customer base.
  • Peak Serum: Peak Serum is a US-based specialty FBS and serum products supplier, closely matching RMBIO's niche in premium and treated sera for research and bioprocessing.
  • Gemini Bio-Products: Gemini Bio manufactures cell culture media, sera, and reagents for research and bioprocessing. Its catalog and customer base substantially overlap with RMBIO's.
  • Bovogen Biologicals: Bovogen is an Australian-based specialty FBS and animal serum producer with a strong catalog of treated sera, equivalent to RMBIO's treated sera and Fetalgro offerings.
  • Animal Technologies: Animal Technologies is a specialty animal-derived sera and biological products supplier, with direct overlap to RMBIO's core sera and protein fraction portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

RMBIO social profiles

Digital presence

RMBIO compliance and trust

Trust signal

Compliance4 records

RMBIO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RMBIO leadership team

Management profile

Number of profiles

RMBIO funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RMBIO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RMBIO

What does RMBIO do?

RMBIO manufactures and supplies sera, protein fractions, and cell culture media supplements used in research, bioprocessing, and clinical diagnostic applications. The company produces biological reagents that support cell culture workflows for pharmaceutical, biotechnology, and diagnostic laboratory customers.

Is RMBIO a public or private company?

RMBIO is a private company. It is classified as unknown and is currently operating.

When was RMBIO founded?

RMBIO was founded in 2004. It employs 11 to 50 people.

Where is RMBIO based?

RMBIO is headquartered in Missoula, United States, in the North America region.

How does RMBIO make money?

Two revenue lines are on record. Sera and Protein Products are the primary driver. The others are custom Solutions and Bulk Orders.

Who are RMBIO's main competitors?

Broad incumbents on record are Thermo Fisher Scientific (Gibco), Merck (Sigma-Aldrich), Cytiva, Corning Life Sciences and Lonza. Direct peers are Atlas Biologicals, Peak Serum, Gemini Bio-Products, Bovogen Biologicals and Animal Technologies.

Does RMBIO have an API?

No public API is recorded for RMBIO.

What industry is RMBIO in?

RMBIO's product category is Cell Culture Media and Biological Reagents. Its primary akta.pro industry code is HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals